Table 1.
Overall Demographics and Surgical Characteristics of Patients Undergoing Immediate Breast Reconstruction after Mastectomy Assessed with the Mastectomy Flap Ischemia Risk Score
| No. (Patients) | 31 |
|---|---|
| No. (breasts) | 45 |
| Age, y | 47.71 |
| Body mass index, kg/m2 | 27.77 |
| Mastectomy indication | Therapeutic: 28 (62.2%); prophylactic: 17 (37.8%) |
| Smoking history | Active: 2 (4.4%); former: 3 (6.7%) |
| Prior radiation | 6 (13.3%) |
| Prior chemotherapy | 18 (40.0%) |
| Lymph node biopsy or dissection performed | 26 (57.8%) |
| Adjuvant radiation | 7 (15.6%) |
| Adjuvant chemotherapy | 6 (13.3%) |
| Pathologic breast cancer stage | 0: 21 (46.7%) |
| IA: 11 (24.4%) | |
| IB: 2 (4.4%) | |
| IIA: 5 (11.1%) | |
| IIB: 3 (6.7%) | |
| IIIA: 2 (4.4%) | |
| IIIC: 1 (2.2%) | |
| Mastectomy type | Skin-sparing mastectomy: 42 (93.3%) Nipple-sparing mastectomy: 3 (6.7%) |
| Mastectomy incision | Ellipse: 42 (93.3%) Inframammary fold: 3 (6.7%) |
| Sternal notch–nipple distance, cm | 22.93 (36) |
| Nipple–inframammary fold distance, cm | 9.36 (36) |
| Breast width, cm | 14.09 (41) |
| Incision–clavicle distance, cm | 15.04 (43) |
| Incision–inframammary fold distance, cm | 6.39 (43) |
| Reconstructive modality | Tissue expander: 29 (64.4%) Autologous: 16 (35.6%) |
| Acellular dermal matrix | 20 (69.0%) |
| Follow-up, mo | 11.16 |